Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481637
Status:
COMPLETED
Last Update Posted:
2019-04-17
First Post:
2007-06-01
Brief Title:
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
Sponsor:
Rockefeller University
Organization:
Rockefeller University
Study Overview
Official Title:
Tumor Immunity in Neurologically Normal Patients
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome PNS can be found in small cell lung cancer and ovarian cancer patients The presence of these cells may play a role in tumor immunity in these patients The protocol involves neurological examinations and collection of blood
Detailed Description:
See brief description
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None